Clinical Physiology and Nuclear Medicine

Medicine & Life Sciences

1. Positron Emission Tomography Computed Tomography 100%
2. Randomized Controlled Trials 85%
3. Radionuclide Imaging 78%
4. Melanoma 75%
5. Bone and Bones 70%
6. Single Photon Emission Computed Tomography Computed Tomography 64%
7. Bone Density 60%
8. Breast Neoplasms 60%
9. CdZnTe 59%
10. Prostatic Neoplasms 59%
11. Resistance Training 57%
12. Single-Photon Emission-Computed Tomography 56%
13. Positron-Emission Tomography 54%
14. Body Composition 52%
15. Gated Blood-Pool Imaging 52%
16. Lymphedema 51%
17. Photon Absorptiometry 51%
18. empagliflozin 51%
19. Blood Pressure 50%
20. Therapeutics 48%
21. Sodium Fluoride 45%
22. Primary Hyperparathyroidism 45%
23. Neoplasm Metastasis 41%
24. Placebos 41%
25. Cardiovascular Diseases 40%
26. Prospective Studies 40%
27. Stroke Volume 39%
28. Exercise 37%
29. Type 2 Diabetes Mellitus 37%
30. Quality of Life 36%
31. Muscles 35%
32. Neoplasms 34%
33. Arthroplasty 33%
34. Fluorodeoxyglucose F18 33%
35. Fats 33%
36. Denmark 32%
37. Glucose 32%
38. Bone Remodeling 31%
39. Population 31%
40. Hip 30%
41. Vitamin D 29%
42. Perfusion 29%
43. Heart Rate 28%
44. Confidence Intervals 28%
45. Colorectal Neoplasms 27%
46. Head and Neck Neoplasms 27%
47. Cetuximab 27%
48. Psoriasis 27%
49. Cohort Studies 26%
50. Electrochemotherapy 26%
51. Thyroid Gland 25%
52. Irinotecan 25%
53. Parathyroid Glands 25%
54. Tumor-Infiltrating Lymphocytes 25%
55. Choline 24%
56. Vascular Stiffness 24%
57. Drug Therapy 24%
58. Recurrence 24%
59. Gamma Cameras 23%
60. Child 22%
61. Prostate-Specific Antigen 22%
62. Body Mass Index 22%
63. Glomerular Filtration Rate 22%
64. Brain Natriuretic Peptide 21%
65. Dopamine D2 Receptors 21%
66. Fatigue 21%
67. Raynaud Disease 20%
68. Response Evaluation Criteria in Solid Tumors 20%
69. Observer Variation 20%
70. Fluorides 20%
71. Healthy Volunteers 20%
72. Heart Failure 20%
73. Diphosphonates 20%
74. Myocardial Perfusion Imaging 20%
75. Cachexia 20%
76. Biopsy 20%
77. Extremities 19%
78. Biomarkers 19%
79. Atherosclerosis 19%
80. Colonic Neoplasms 19%
81. Urokinase Plasminogen Activator Receptors 19%
82. Inflammation 19%
83. Obesity 19%
84. Antipsychotic Agents 18%
85. Weights and Measures 18%
86. Pain 18%
87. Pulse Wave Analysis 18%
88. Apnea 17%
89. Carotid-Femoral Pulse Wave Velocity 17%
90. Lymph Node Excision 16%
91. Cell- and Tissue-Based Therapy 16%
92. Kidney 16%
93. Isotopes 15%
94. Elderly 15%
95. Cerebrovascular Circulation 15%
96. X-Rays 15%
97. Survival 15%
98. Weight Loss 15%
99. Head 15%
100. Skin 15%